Patent · US Active

Antibodies to EGF receptor epitope peptides and uses thereof

US8652473B2 · kind B2 · utility

8Cited by

12References

20Claims

0Family size

Assignees

Inventors

Terrance Grant Johns · Melbourne, AU
Andrew Scott · Melbourne, AU
Antony Wilks Burgess · Melbourne, AU
Lloyd J. Old · New York, US
Timothy Adams · Melbourne, AU
K. Dane Wittrup · Sharon, US
Ginger Chao · Beaumont, US
Peter Anthony Hoyne · Melbourne, AU

Key dates

Filing date	Jan 29, 2010
Grant date	Feb 18, 2014
Priority date	—
Expiry date	Jul 20, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K39/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to growth factor receptor epitope peptides, particularly EGF family receptor epitope peptides. The invention also relates to the use of the receptor peptides in generating antibodies which have anti-tumor or anti-cancer activity or in stimulating an immunological response. The invention further relates to antibodies specifically directed against the receptor peptides. Methods for generating an immune response and for treatment of tumors and cancer are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.